Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2007
05/09/2007EP1781279A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
05/09/2007EP1781276A2 Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
05/09/2007EP1781273A2 Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
05/09/2007EP1781272A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
05/09/2007EP1680418B1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
05/09/2007EP1578420A4 Treatment of cognitive impairment using a selective dopamine d1 receptor agonist
05/09/2007EP1565451B1 Halothienoyl-cyclopropane-1-carboxylic acid derivatives
05/09/2007EP1545511B1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
05/09/2007EP1487469A4 Co-beadlet of dha and rosemary and methods of use
05/09/2007EP1435874A4 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
05/09/2007EP1406883B1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
05/09/2007EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/09/2007EP1365788B1 Thrombomodulin analogs for use in recovery of spinal cord injury
05/09/2007EP1244456B1 A pyrrolidineacetamide derivative for treatment of chronic or neuropathic pain
05/09/2007EP1183245B1 Selective npy (y5) antagonists
05/09/2007EP1169058B1 Insulin-like growth factor binding protein-4 protease
05/09/2007EP1041992A4 Hyperhydrated citicoline, process and use
05/09/2007EP0937032B1 Substituted gamma aminobutyric acids as pharmaceutical agents
05/09/2007CN1960986A Butyrylcholinesterase selective inhibitors
05/09/2007CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
05/09/2007CN1960984A Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists
05/09/2007CN1960983A Arylsulfonyl benzodioxanes useful for modulation the 5-HT6 receptor, the 5-HT2areceptor or both
05/09/2007CN1960981A Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
05/09/2007CN1960977A Quinazoline derivative
05/09/2007CN1960974A Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/09/2007CN1960971A Substituted pyrrolidine-2-ones
05/09/2007CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof
05/09/2007CN1960781A Therapeutic combination for treatment of alzheimers disease
05/09/2007CN1960740A Method of preventing nodavirus infection and therapeutic method
05/09/2007CN1960739A Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
05/09/2007CN1960724A Use of rotigotine for treating and preventing parkinson's plus syndrome
05/09/2007CN1958792A Method for obtaining inner morphine peptide, and application in center of treating pain
05/09/2007CN1958788A Gene recombined virus of human neurenergen 3
05/09/2007CN1958570A Method for preparing ropinirole
05/09/2007CN1958048A Application of extractive of corn leaves in use for anti depression, and improving sexual function
05/09/2007CN1957979A Medication with effect of being sobered up from wine and protecting liver, and method for making up preparation
05/09/2007CN1957970A Compositions improving brain functions
05/09/2007CN1957948A Modified montmorillonite, preparation method and application
05/09/2007CN1957933A Application of theanine in preparing medication of curing sequela of apoplexy or convalescent period of apoplexy
05/09/2007CN1957909A Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
05/09/2007CN1314684C Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder
05/09/2007CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase
05/09/2007CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity
05/09/2007CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase
05/09/2007CN1314669C 2,7-substituted indoles and their use as 5-HT6 modulators
05/09/2007CN1314408C Compound traditional Chinese medicine preparation for treating symptom of delayed giving-up of opium, and its application
05/09/2007CN1314403C Composition of paeoniflorin and albiflorin and its preparation method
05/08/2007USRE39616 Aminoindan derivatives
05/08/2007US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics
05/08/2007US7214772 Sialoadhesin family member-2 (SAF-2)
05/08/2007US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
05/08/2007US7214692 Medical use for tachykinin antagonists
05/08/2007US7214689 Isoquinoline compounds
05/08/2007US7214688 Compounds
05/08/2007US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
05/08/2007US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/08/2007US7214657 Method of transporting a chimeric hybrid molecule across the blood brain barrier
05/08/2007US7214495 Screening method
05/08/2007US7214483 KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies
05/08/2007US7214372 Culture regeneration of nervous systems; cell differentiation; wound healing agent
05/08/2007CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
05/08/2007CA2432138C New process for the preparation of eletriptan
05/08/2007CA2342950C New process for preparing 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thia zepine and application in the synthesis of tianeptine
05/08/2007CA2342435C A pharmaceutical composition for inhibiting non-intentional behavior and use of a running neuron inhibitory substance for producing the pharmaceutical composition
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2310593C Metalloproteinase inhibitors
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/08/2007CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
05/03/2007WO2007050726A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
05/03/2007WO2007050723A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
05/03/2007WO2007050719A1 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1] octane-3-carboxylic acid amide as ligand for the nociceptin receptor orl-1
05/03/2007WO2007050697A2 Compositions and methods for the administration psychotropic drugs which modulate body weight
05/03/2007WO2007050612A1 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace)
05/03/2007WO2007050522A1 Derivatives for modulation of ion channels
05/03/2007WO2007050377A1 Enhanced efficacy benzisoxazole derivative dosage forms and methods
05/03/2007WO2007050353A2 Tricyclic compounds useful as oxytocin receptor agonists
05/03/2007WO2007049932A1 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same
05/03/2007WO2007049828A1 Therapeutic agent for unstable cerebrospinal pressure syndrome
05/03/2007WO2007049825A1 P2x4 receptor antagonist
05/03/2007WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient
05/03/2007WO2007049798A1 Novel benzoxathiin derivative
05/03/2007WO2007049690A1 Formation/elongation of axon by inhibiting the expression or function of singar and application to nerve regeneration
05/03/2007WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same
05/03/2007WO2007049626A1 Oral solid preparation containing cabergoline
05/03/2007WO2007049532A1 Aminodihydrothiazine derivative
05/03/2007WO2007049468A1 Cerebral infarction-preventive agent
05/03/2007WO2007049409A1 Recombinant hsv useful for treatment of human glioma
05/03/2007WO2007049262A1 Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
05/03/2007WO2007048846A1 Use of iron-chelating compounds, cyclic adenosine monophosphate-increasing compounds or combinations thereof for treating axonal lesions in the cns
05/03/2007WO2007048787A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
05/03/2007WO2007048779A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists